Fonte: Revista da Associação Médica Brasileira. Unidades: FO, FM
Assunto: NEOPLASIAS MAMÁRIAS
ABNT
GOBBI, Helenice et al. Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group. Revista da Associação Médica Brasileira, v. 70, n. 10, 2024Tradução . . Disponível em: https://www.scielo.br/j/ramb/a/k76KVyqyLWsbhrsXj9pxMwg/. Acesso em: 16 nov. 2024.APA
Gobbi, H., Soares, F. A., Carvalho, F. M., De Brot, M., Logullo, A. F., Silva, C. A. M., et al. (2024). Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group. Revista da Associação Médica Brasileira, 70( 10). doi:10.1590/1806-9282.20240313NLM
Gobbi H, Soares FA, Carvalho FM, De Brot M, Logullo AF, Silva CAM, Landeiro L, Rahal R, Barrios CH. Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group [Internet]. Revista da Associação Médica Brasileira. 2024 ; 70( 10):[citado 2024 nov. 16 ] Available from: https://www.scielo.br/j/ramb/a/k76KVyqyLWsbhrsXj9pxMwg/Vancouver
Gobbi H, Soares FA, Carvalho FM, De Brot M, Logullo AF, Silva CAM, Landeiro L, Rahal R, Barrios CH. Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group [Internet]. Revista da Associação Médica Brasileira. 2024 ; 70( 10):[citado 2024 nov. 16 ] Available from: https://www.scielo.br/j/ramb/a/k76KVyqyLWsbhrsXj9pxMwg/